Updated insights into the T cell-mediated immune response against SARS-CoV-2: a step towards efficient and reliable vaccines
M Dhawan, AA Rabaan, MMA Fawarah, SA Almuthree… - Vaccines, 2023 - mdpi.com
The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune
response elicited through presently available vaccination makes it essential to recognize the …
response elicited through presently available vaccination makes it essential to recognize the …
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19
Clinical outcomes from infection with SARS-CoV-2, the cause of the COVID-19 pandemic,
are remarkably variable ranging from asymptomatic infection to severe pneumonia and …
are remarkably variable ranging from asymptomatic infection to severe pneumonia and …
Dynamic inflammatory response among routine laboratory biomarkers and their predictive ability for mortality in patients with severe COVID-19
A Cortes-Telles, AL Gutiérrez-Solis… - Frontiers in …, 2022 - frontiersin.org
Background The severity of coronavirus disease 2019 (COVID-19) is related to several
factors, including age, sex, and comorbidities (obesity, type 2 diabetes, and hypertension) …
factors, including age, sex, and comorbidities (obesity, type 2 diabetes, and hypertension) …
Th-1, Th-2, Th-9, Th-17, Th-22 type cytokine concentrations of critical COVID-19 patients after treatment with Remdesivir
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread around the
world causing a pandemic known as coronavirus disease 2019 (COVID-19). Cytokine storm …
world causing a pandemic known as coronavirus disease 2019 (COVID-19). Cytokine storm …
Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA. 1 infection of K18-hACE2 mice
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus
Disease 2019 (COVID-19), which can result in severe disease often characterised by …
Disease 2019 (COVID-19), which can result in severe disease often characterised by …
The predictive markers of severity and mortality in hospitalized hemodialysis patients with COVID‐19 during Omicron epidemic
M Banshodani, H Kawanishi, T Hirai… - Therapeutic …, 2023 - Wiley Online Library
Introduction Predictive markers and prognosis remain unclear in hospitalized hemodialysis
(HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic …
(HD) patients with coronavirus disease 2019 (COVID‐19) during the Omicron epidemic …
Development of a new HISCL automated CXCL9 immunoassay
T Hasegawa, M Yoshida, S Watanabe, T Kondo… - Scientific Reports, 2023 - nature.com
Abstract C–X–C motif chemokine ligand 9 (CXCL9), a candidate biomarker, reflects type 1
(T1) inflammation pathology. Here, we report the analytical performance and clinical …
(T1) inflammation pathology. Here, we report the analytical performance and clinical …
Role of Inflammatory Markers in Severity, ICU Admission, and Mortality in COVID-19: A Systematic Review and Meta-analysis of 79,934 Patients
HO Abdullah, SA Braim, MA Rasool, DM Abdalla… - Barw Medical …, 2024 - barw.krd
Introduction Despite extensive investigations into the roles of inflammatory biomarkers in the
prognosis of COVID-19 through systematic reviews and meta-analyses, they are limited by …
prognosis of COVID-19 through systematic reviews and meta-analyses, they are limited by …